Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
C31004A Phase 2, Randomized Study of MLN0128 (a Dual TORC1/2 Inhibitor), MLN0128+MLN1117 (a PI3Kα Inhibitor), Weekly Paclitaxel, or the Combination of Weekly Paclitaxel and MLN0128 in Women With Advanced, Recurrent, or Persistent Endometrial CancerHirte, Dr HalOpenNCT02725268
RTOG 1174 (OUTBACK)A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK TrialElit, Dr LaurieOpenNCT01414608
PHL-086A Study of XL184 (Cabozantinib) in Endometrial CancerHirte, Dr HalOn holdNCT01815151
Download PDF